Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reichardt

Showing results (71-80 of 193) with videos related to

Pageof 20
Sort By:
European Radiology|September 1, 2005
Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRIChristian Stroszczynski, Dominik Jost, Peter Reichardt, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 22, 2008
Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomasOliver Dudeck, Martin Zeile, Daniel Pink, et al.
Gynecologic Oncology|April 9, 2018
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancerJoyce Liu, Shibani Nicum, Peter Reichardt, et al.
Molecular & Cellular Proteomics : MCP|June 12, 2013
Multimolecular analysis of stable immunological synapses reveals sustained recruitment and sequential assembly of signaling clustersLars Philipsen, Thomas Engels, Kerstin Schilling, et al.
Cancers|February 6, 2021
Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib TherapyNikolaos Vassos, Jens Jakob, Georg Kähler, et al.
Pediatric Blood & Cancer|April 25, 2017
Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trialJudith Amalie Frank, Andreas Ranft, Michael Paulussen, et al.
Plos One|March 6, 2008
Signaling signatures and functional properties of anti-human CD28 superagonistic antibodiesZoe Waibler, Linda Y Sender, Camilla Merten, et al.
Frontiers in Oncology|September 29, 2017
Three-Dimensional Patient-Derived <i>In Vitro</i> Sarcoma Models: Promising Tools for Improving Clinical Tumor ManagementManuela Gaebler, Alessandra Silvestri, Johannes Haybaeck, et al.
Cancer Treatment and Research|March 10, 2010
Osteosarcoma: the COSS experienceStefan Bielack, Herbert Jürgens, Gernot Jundt, et al.
Journal of Pediatric Hematology/Oncology|May 7, 2002
Recurrent polytopic chromaffin paragangliomas in a 9-year-old boy resulting from a novel germline mutation in the von Hippel-Lindau genePeter Reichardt, Thomas W Apel, Manfred Domula, et al.
Pageof 20

Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
European Radiology|September 1, 2005
Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRIChristian Stroszczynski, Dominik Jost, Peter Reichardt, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 22, 2008
Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomasOliver Dudeck, Martin Zeile, Daniel Pink, et al.
Gynecologic Oncology|April 9, 2018
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancerJoyce Liu, Shibani Nicum, Peter Reichardt, et al.
Molecular & Cellular Proteomics : MCP|June 12, 2013
Multimolecular analysis of stable immunological synapses reveals sustained recruitment and sequential assembly of signaling clustersLars Philipsen, Thomas Engels, Kerstin Schilling, et al.
Cancers|February 6, 2021
Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib TherapyNikolaos Vassos, Jens Jakob, Georg Kähler, et al.
Pediatric Blood & Cancer|April 25, 2017
Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trialJudith Amalie Frank, Andreas Ranft, Michael Paulussen, et al.
Plos One|March 6, 2008
Signaling signatures and functional properties of anti-human CD28 superagonistic antibodiesZoe Waibler, Linda Y Sender, Camilla Merten, et al.
Frontiers in Oncology|September 29, 2017
Three-Dimensional Patient-Derived <i>In Vitro</i> Sarcoma Models: Promising Tools for Improving Clinical Tumor ManagementManuela Gaebler, Alessandra Silvestri, Johannes Haybaeck, et al.
Cancer Treatment and Research|March 10, 2010
Osteosarcoma: the COSS experienceStefan Bielack, Herbert Jürgens, Gernot Jundt, et al.
Journal of Pediatric Hematology/Oncology|May 7, 2002
Recurrent polytopic chromaffin paragangliomas in a 9-year-old boy resulting from a novel germline mutation in the von Hippel-Lindau genePeter Reichardt, Thomas W Apel, Manfred Domula, et al.
Pageof 20